DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Intellia Therapeutics
Intellia Therapeutics
ARK GENOMIC REVOLUTION MULTI SECTOR ETF (ARKG) HOLDINGS As of 09/27/2021
United States Securities and Exchange Commission Washington, D.C
Questions About CRISPR
Market Deep Dive Report CRISPR Therapeutics June 2020
Intellia Therapeutics Annual Report 2021
News & Analysis
CRISPR Genome-Editing
CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Provide Update on U.S Federal Circuit Decision Upholding the Ruling by U.S
INTELLIA THERAPEUTICS, INC. (Name of Registrant As Specified in Its Charter)
Nobel Laureate Jennifer Doudna and the Bio Revolution Catalyst COLLEGE of CHEMISTRY UNIVERSITY of CALIFORNIA, BERKELEY
CRISPR Steps Closer to Centre Stage As Astrazeneca Piles In
INTELLIA THERAPEUTICS, INC. (Exact Name of Registrant As Specified in Its Charter) Delaware 36-4785571 (State Or Other Jurisdiction of (I.R.S
Zafgen Charts Unique Path to Obesity Approval
Intellia Therapeutics Annual Report 2020
Portfolio Holdings Listing Select Biotechnology Portfolio As of July
A Modular CRISPR/Cas9 Genome Editing Platform for Durable Therapeutic Knockout and Targeted Gene Insertion Applications
INTELLIA THERAPEUTICS, INC. (Exact Name of Registrant As Specified in Its Charter)
Moving Genome Editing to the Clinic: from Technology To
Top View
INTELLIA THERAPEUTICS, INC. (Exact Name of Registrant As Specified in Its Charter)